Profile data is unavailable for this security.
About the company
China Meheco Group Co., Ltd. is mainly engaged in the operation of industrial pharmaceutical, commercial pharmaceutical and international trading businesses. Industrial Pharmaceutical segment mainly involves in the manufacture and distribution of chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, herbal decoction pieces and other pharmaceutical products. Commercial Pharmaceutical segment is mainly engaged in the wholesale and distribution of pharmaceuticals and medical devices. Trading segment is mainly engaged in the international exporting business and medical resourcing introduction.
- Revenue in CNY (TTM)35.13bn
- Net income in CNY901.08m
- Incorporated1997
- Employees8.39k
- LocationChina Meheco Group Co LtdNo. 18Guangming Middle StreetDongcheng DistrictBEIJING 100073ChinaCHN
- Phone+86 1 067164267
- Fax+86 1 067152359
- Websitehttp://www.meheco.com
More ▼
Mergers & acquisitions
Acquired company | 600056:SHH since announced | Transaction value |
---|---|---|
Hainan General & Kangli Pharmaceutical Co Ltd | -12.14% | 26.97m |
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
Holder | Shares | % Held |
---|---|---|
China Investment Corp. (Investment Management)as of 30 Sep 2023 | 30.51m | 2.04% |
China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 9.60m | 0.64% |
The Vanguard Group, Inc.as of 02 Oct 2024 | 3.56m | 0.24% |
Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 2.25m | 0.15% |
GF Fund Management Co., Ltd.as of 30 Jun 2024 | 1.95m | 0.13% |
Tian Hong Asset Management Co., Ltd.as of 30 Jun 2024 | 1.77m | 0.12% |
China Asset Management Co., Ltd.as of 30 Jun 2024 | 1.66m | 0.11% |
Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 1.52m | 0.10% |
Dimensional Fund Advisors LPas of 03 Oct 2024 | 1.50m | 0.10% |
China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 979.15k | 0.07% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.